denosumab
Showing 26 - 50 of 126
Osteoporosis, Bone Mineral Density Trial in Douliu (Denosumab)
Recruiting
- Osteoporosis
- Bone Mineral Density
- Denosumab
-
Douliu, Yunlin County, TaiwanNational Taiwan University Hospital, Yunlin branch
Oct 22, 2021
Low Bone Mineral Density, Postmenopausal Osteoporosis Trial (Placebo to Romosozumab, Alendronate, Teriparatide)
Completed
- Low Bone Mineral Density
- Postmenopausal Osteoporosis
- Placebo to Romosozumab
- +6 more
- (no location specified)
Sep 9, 2022
Postmenopausal Osteoporosis Trial in Boston (Teriparatide, Denosumab)
Completed
- Postmenopausal Osteoporosis
- Teriparatide
- Denosumab
-
Boston, MassachusettsMassachusetts General Hospital
Jul 28, 2022
Denosumab and Screw Internal Fixation of Osteoporotic Vertebral Compression Fracture Trial in Shenzhen (Denosumab)
Recruiting
- Denosumab and Screw Internal Fixation of Osteoporotic Vertebral Compression Fracture
- Denosumab
-
Shenzhen, Guangdong, ChinaShenzhenPH
Sep 22, 2021
Gout Trial in Birmingham (Denosumab)
Completed
- Gout
- Denosumab
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 22, 2021
Infertility, Male Trial in Copenhagen (Denosumab, Sodium chloride)
Recruiting
- Infertility, Male
- Denosumab
- Sodium chloride
-
Copenhagen, DenmarkDepartment of Growth and Reproduction, Rigshospitalet
Jan 14, 2022
Osteogenesis Imperfecta (OI) Trial in Worldwide (Denosumab, No treatment, Alternative osteoporosis medications)
Terminated
- Osteogenesis Imperfecta (OI)
- Denosumab
- Alternative osteoporosis medications
-
Los Angeles, California
- +21 more
Nov 28, 2022
Denosumab vs Zoledronate Trial in Shenzhen (Denosumab, Zoledronic acid)
Recruiting
- Denosumab vs Zoledronate
- Denosumab
- Zoledronic acid
-
Shenzhen, Guangdong, ChinaShenzhenPH
Oct 22, 2021
Postmenopausal Osteoporosis Trial in Boston (Romosozumab, Denosumab)
Recruiting
- Postmenopausal Osteoporosis
- Romosozumab
- Denosumab
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2022
Breast Cancer Trial in Houston (Ra-223 dichloride, Denosumab, Hormone Therapy)
Completed
- Breast Cancer
- Ra-223 dichloride
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 5, 2021
Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)
Not yet recruiting
- Nonalcoholic Fatty Liver
- Osteoporosis, Postmenopausal
- Denosumab
- Alendronate Sodium
- (no location specified)
Aug 6, 2022
BRCA1 Mutation, Breast Cancer, Breast Diseases Trial in United States (Denosumab, Placebo, Quality-of-Life Assessment)
Not yet recruiting
- BRCA1 Mutation
- +5 more
- Denosumab
- +2 more
- (no location specified)
Jul 19, 2021
Giant Cell Tumor of Bone Trial in Beijing (Narlumosbart, Denosumab)
Not yet recruiting
- Giant Cell Tumor of Bone
- Narlumosbart
- Denosumab
-
Beijing, Beijing, ChinaBeijing Ji Shui Tan Hospital
Apr 16, 2023
Osteoporosis, Spinal Cord Injuries Trial in West Orange, Bronx (Romoszumab, Denosumab, Placebo)
Recruiting
- Osteoporosis
- Spinal Cord Injuries
- Romoszumab
- +2 more
-
West Orange, New Jersey
- +1 more
Apr 1, 2022
PraG With RANKL Inhibitor for Treatment of Advanced Multiple
Not yet recruiting
- Metastatic Solid Tumor
- Denosumab
-
Suzhou, Jiangsu, ChinaThe Second Affiliated Hospital of Soochow University
Aug 16, 2022
Postmenopausal Osteoporosis Trial in Changchun (JMT103, Denosumab, Placebo)
Recruiting
- Postmenopausal Osteoporosis
- JMT103
- +2 more
-
Changchun, Jilin, ChinaThe Second Hospital of Jilin University
Jul 14, 2022
Calcific Aortic Stenosis Trial in Edinburgh (Denosumab, Alendronic Acid, Denosumab Placebo)
Completed
- Calcific Aortic Stenosis
- Denosumab
- +3 more
-
Edinburgh, United KingdomClinical Research Facility University of Edinburgh
Oct 13, 2021
Hand Osteoarthritis Trial in Gent (denosumab, Placebo, Calcium/Vit D supplementation)
Completed
- Hand Osteoarthritis
- denosumab
- +2 more
-
Gent, BelgiumUZ Ghent
May 25, 2021
Postmenopausal Osteoporosis Trial in Boston (denosumab, teriparatide, Zoledronic acid)
Completed
- Postmenopausal Osteoporosis
- denosumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jan 27, 2021
Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)
Not yet recruiting
- Metastatic Breast Cancer
- ATI-2231
- +3 more
-
Kansas City, Kansas
- +2 more
Mar 16, 2023
Infertility, Male Trial in Copenhagen (Denosumab)
Active, not recruiting
- Infertility, Male
- Denosumab
-
Copenhagen, DenmarkDepartment of Growth and Reproduction, Rigshospitalet
Jan 27, 2021
Osteoporosis, Systemic Mastocytosis Trial in France (Denosumab, Placebo)
Active, not recruiting
- Osteoporosis
- Systemic Mastocytosis
- Denosumab
- Placebo
-
Besançon, France
- +10 more
Apr 13, 2021
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,
Completed
- Advanced Malignant Neoplasm
- +3 more
- Anakinra
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 24, 2021